Blumencranz P, Habibi M, Shivers S, Acs G, et al. ASO Visual Abstract: The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy. Ann Surg Oncol 2023 Oct 3. doi: 10.1245/s10434-023-14317.
PMID: 37787953